Show Summary Details
Page of

Diabetic retinopathy: reasons for screening 

Diabetic retinopathy: reasons for screening
Chapter:
Diabetic retinopathy: reasons for screening
Author(s):

Paul Galsworthy

DOI:
10.1093/med/9780198834458.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 June 2022

Diabetic retinopathy (DR) is still the most common form of eye disease for people with diabetes, but is no longer the leading cause of blindness in the working-age population. Patients with visual loss caused by DR is often as a result of late presentation to screening services, poor or non-attendance of diabetes care, and/or hospital eye services. Diabetes care is accountable for 10% of the NHS budget—most of this money is spent on inpatient care, rather than on prevention. DR meets the screening criteria of Wilson and Jungner for a successful programme, as it has important adverse effects, laser and intravitreal treatment is effective, it can be easily detected by digital imaging, which is an acceptable test, and is cost effective.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.